Since then, several studies have shown that early-life factors, including the birth mode, antibiotics, nutrition, infection, ...

The suits were filed in rapid succession in the days after the NIH announced on February 7 that it would cap so-called ...

No treatment or drug gets to market without a clinical trial. Many of those trials don’t just happen in academic settings, ...

It began one hot summer morning as I awoke in the thorny embrace of brambles in a hedge on the South Downs, UK. The bicycle between my legs had morphed from transport to sleeping pallet. Marking ...

The sale of FibroGen China to AstraZeneca PLC simplifies the company's operations and cleans up its balance sheet, CEO Thane ...

Glover, a dedicated instructor at SC State University, was honored with the 2025 Frank R. Kleffner Lifetime Clinical Career ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Leaders with the University of Tennessee, Vanderbilt University, St. Jude Children’s Research Hospital and more have written ...

There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.

Under the Trump administration, the National Institutes of Health has placed a 15 percent cap on indirect research costs—a ...

Inspired by the 2017 March for Science that drew millions, organizers are planning rallies in Washington D.C., Boston and ...

The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...